PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
86.40%
Net income growth above 1.5x CRWD's 30.05%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.80%
Negative yoy D&A while CRWD is 6.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1295.65%
Well above CRWD's 61.99% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
9.48%
SBC growth well above CRWD's 13.23%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-183.70%
Both reduce yoy usage, with CRWD at -200.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-201.49%
Both yoy AR lines negative, with CRWD at -124.34%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.26%
Growth well above CRWD's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-754.77%
Negative yoy while CRWD is 14.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-18.63%
Both yoy CFO lines are negative, with CRWD at -13.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
13.56%
Lower CapEx growth vs. CRWD's 64.44%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-61.54%
Negative yoy acquisition while CRWD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
59.13%
Purchases well above CRWD's 31.64%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-46.16%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
92.33%
Investing outflow well above CRWD's 52.10%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-27.34%
We cut debt repayment yoy while CRWD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.29%
Both yoy lines negative, with CRWD at -200.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-151.10%
We cut yoy buybacks while CRWD is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.